News

Video

Organizations Can Help Patients with CML Face the ‘Long Treatment Journey’

Author(s):

A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.

A diagnosis of chromic myeloid leukemia (CML) can lead to a “long treatment journey,” but there are organizations and resources that can help with some of the common issues patients and their loved ones face, said Claire Saxton, executive vice president of Insights and Impact at Cancer Support Community.

In an interview with CURE® at the 2024 American Society of Clinical Oncology Annual Meeting, Saxton discussed where patients with CML and caregivers can look for help. These organizations can offer services such as financial counseling, support groups and mental health professionals.

“This is a long treatment journey, and there is a huge impact on your life and your family’s life, and also on your mental health,” Saxton said in the interview.

READ MORE: Mending the Mind After Cancer

Transcript:

This is a long treatment journey, and there is a huge impact on your life on your family's life and also on your mental health.

Reach out for resources. It can be hard to find them initially, but there are a number of patient advocacy groups like Cancer Support Community, [Leukemia & Lymphoma Society], CML Buster [Foundation] who are here and ready to help with financial counsellors, support groups, access to mental health professionals, because those are the kinds of things that are going to help give you the support that you need to get through this long term.

Editor's Note: This program was made possible with support from Novartis Pharmaceuticals.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Related Content